P2X7 Receptor as a Therapeutic Target

Advances in Protein Chemistry and Structural Biology

Volumn 104, Issue , 2016, Pages 39-79

  De Marchi, Elena ^a   Orioli, Elisa ^a   Dal Ben, Diego ^b   Adinolfi, Elena ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

ATP; Cancer; Inflammation; Ligands; Mood disorders; Neurodegeneration; Osteoporosis; P2X7; SNPs

Indexed keywords

BIOLOGICAL MARKER; PURINERGIC P2X RECEPTOR AGONIST; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X7 RECEPTOR; LIGAND; P2XR RECEPTOR, HUMAN;

ALLOSTERISM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; DIABETES MELLITUS; EPILEPSY; HUMAN; HUNTINGTON CHOREA; INFECTION; INFLAMMATION; MOOD DISORDER; MULTIPLE SCLEROSIS; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

HUMANS; INFECTION; INFLAMMATION; LIGANDS; MOLECULAR TARGETED THERAPY; NEOPLASMS; OSTEOPOROSIS; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7;

EID: 84952690683     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apcsb.2015.11.004     Document Type: Article

References (221)

1. M.P. Abbracchio, G. Burnstock, A. Verkhratsky, and H. Zimmermann Purinergic signalling in the nervous system: An overview Trends in Neurosciences 32 2009 19 29
2. E. Adinolfi, F. Amoroso, and A.L. Giuliani P2X7 receptor function in bone-related cancer Journal of Osteoporosis 2012 2012 637863
3. E. Adinolfi, M.G. Callegari, M. Cirillo, P. Pinton, C. Giorgi, D. Cavagna, and et al. Expression of the P2X7 receptor increases the Ca2 + content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis The Journal of Biological Chemistry 284 2009 10120 10128
4. E. Adinolfi, M.G. Callegari, D. Ferrari, C. Bolognesi, M. Minelli, M.R. Wieckowski, and et al. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth Molecular Biology of the Cell 16 2005 3260 3272
5. E. Adinolfi, M. Capece, F. Amoroso, E. De Marchi, and A. Franceschini Emerging roles of P2X receptors in cancer Current Medicinal Chemistry 22 2015 878 890
6. E. Adinolfi, M. Capece, A. Franceschini, S. Falzoni, A.L. Giuliani, A. Rotondo, and et al. Accelerated tumor progression in mice lacking the ATP receptor P2X7 Cancer Research 75 2015 635 644
7. E. Adinolfi, M. Cirillo, R. Woltersdorf, S. Falzoni, P. Chiozzi, P. Pellegatti, and et al. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor The FASEB Journal 24 2010 3393 3404
8. E. Adinolfi, L. Melchiorri, S. Falzoni, P. Chiozzi, A. Morelli, A. Tieghi, and et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia Blood 99 2002 706 708
9. E. Adinolfi, L. Raffaghello, A.L. Giuliani, L. Cavazzini, M. Capece, P. Chiozzi, and et al. Expression of P2X7 receptor increases in vivo tumor growth Cancer Research 72 2012 2957 2969
10. A. Agrawal, K.A. Buckley, K. Bowers, M. Furber, J.A. Gallagher, and A. Gartland The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro Purinergic Signal 6 2010 307 315
11. H.J. Agteresch, S.A. Burgers, A. van der Gaast, J.H. Wilson, and P.C. Dagnelie Randomized clinical trial of adenosine 5'-triphosphate on tumor growth and survival in advanced lung cancer patients Anticancer Drugs 14 2003 639 644
12. Y. Alamanos, P.V. Voulgari, and A.A. Drosos Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review Seminars in Arthritis and Rheumatism 36 2006 182 188
13. A. Al-Shukaili, J. Al-Kaabi, B. Hassan, T. Al-Araimi, M. Al-Tobi, M. Al-Kindi, and et al. P2X7 receptor gene polymorphism analysis in rheumatoid arthritis International Journal of Immunogenetics 38 2011 389 396
14. L.A. Alves, R.J. Bezerra, R.X. Faria, L.G. Ferreira, and V. da Silva Frutuoso Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain Molecules 18 2013 10953 10972
15. E.P. Amaral, S.C. Ribeiro, V.R. Lanes, F.M. Almeida, M.R. de Andrade, C.C. Bomfim, and et al. Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis PLoS Pathogens 10 2014 e1004188
16. F. Amoroso, M. Capece, A. Rotondo, D. Cangelosi, M. Ferracin, A. Franceschini, and et al. The P2X7 receptor is a key modulator of the PI3K/GSK3beta/VEGF signaling network: Evidence in experimental neuroblastoma Oncogene 34 2015 5240 5251
17. F. Amoroso, S. Falzoni, E. Adinolfi, D. Ferrari, and F. Di Virgilio The P2X7 receptor is a key modulator of aerobic glycolysis Cell Death & Disease 3 2012 e370
18. S. Apolloni, S. Amadio, C. Montilli, C. Volonte, and N. D'Ambrosi Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis Human Molecular Genetics 22 2013 4102 4116
19. S. Apolloni, S. Amadio, C. Parisi, A. Matteucci, R.L. Potenza, M. Armida, and et al. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis Disease Models & Mechanisms 7 2014 1101 1109
20. S. Apolloni, P. Fabbrizio, C. Parisi, S. Amadio, and C. Volonte Clemastine confers neuroprotection and induces an anti-inflammatory phenotype in SOD1 mouse model of amyotrophic lateral sclerosis Molecular Neurobiology 2014 1 14 10.1007/s12035-014-9019-8 [Epub ahead of print]
21. S. Apolloni, C. Parisi, M.G. Pesaresi, S. Rossi, M.T. Carri, M. Cozzolino, and et al. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis Journal of Immunology 190 2013 5187 5195
22. M. Barbera-Cremades, A. Baroja-Mazo, A.I. Gomez, F. Machado, F. Di Virgilio, and P. Pelegrin P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release The FASEB Journal 26 2012 2951 2962
23. N. Barden, M. Harvey, B. Gagne, E. Shink, M. Tremblay, C. Raymond, and et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 141B 2006 374 382
24. O.R. Baricordi, L. Melchiorri, E. Adinolfi, S. Falzoni, P. Chiozzi, G. Buell, and et al. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor The Journal of Biological Chemistry 274 1999 33206 33208
25. R. Bartlett, L. Stokes, and R. Sluyter The P2X7 receptor channel: Recent developments and the use of P2X7 antagonists in models of disease Pharmacological Reviews 66 2014 638 675
26. S. Beijer, P.S. Hupperets, B.E. van den Borne, S.R. Eussen, A.M. van Henten, M. van den Beuken-van Everdingen, and et al. Effect of adenosine 5'-triphosphate infusions on the nutritional status and survival of preterminal cancer patients Anti-Cancer Drugs 20 2009 625 633
27. S. Beijer, P.S. Hupperets, B.E. van den Borne, N.E. Wijckmans, C. Spreeuwenberg, P.A. van den Brandt, and et al. Randomized clinical trial on the effects of adenosine 5'-triphosphate infusions on quality of life, functional status, and fatigue in preterminal cancer patients Journal of Pain and Symptom Management 40 2010 520 530
28. L.S. Bergamin, E. Braganhol, F. Figueiro, E.A. Casali, R.F. Zanin, J. Sevigny, and et al. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium Journal of Cellular Biochemistry 116 2015 721 729
29. L.P. Bernier, A.R. Ase, and P. Seguela Post-translational regulation of P2X receptor channels: Modulation by phospholipids Frontiers in Cellular Neuroscience 7 2013 226
30. P. Betschmann, B. Bettencourt, D. Donnelly-Roberts, M. Friedman, J. George, G. Hirst, and et al. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists Bioorganic & Medicinal Chemistry Letters 18 2008 3848 3851
31. G. Bianchi, M. Vuerich, P. Pellegatti, D. Marimpietri, L. Emionite, I. Marigo, and et al. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment Cell Death & Disease 5 2014 e1135
32. D.R. Borchelt, M.K. Lee, H.S. Slunt, M. Guarnieri, Z.S. Xu, P.C. Wong, and et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity Proceedings of the National Academy of Sciences of the United States of America 91 1994 8292 8296
33. W.B. Bowler, K.A. Buckley, A. Gartland, R.A. Hipskind, G. Bilbe, and J.A. Gallagher Extracellular nucleotide signaling: A mechanism for integrating local and systemic responses in the activation of bone remodeling Bone 28 2001 507 512
34. E. Braganhol, F. Kukulski, S.A. Levesque, M. Fausther, E.G. Lavoie, A. Zanotto-Filho, and et al. Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells Biochimica et Biophysica Acta 1852 2015 120 130
35. L.E. Browne, L.H. Jiang, and R.A. North New structure enlivens interest in P2X receptors Trends in Pharmacological Sciences 31 2010 229 237
36. G. Burnstock Purinergic signalling and disorders of the central nervous system Nature Reviews. Drug Discovery 7 2008 575 590
37. G. Burnstock, and F. Di Virgilio Purinergic signalling and cancer Purinergic Signal 9 2013 491 540
38. G. Cabrini, S. Falzoni, S.L. Forchap, P. Pellegatti, A. Balboni, P. Agostini, and et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes Journal of Immunology 175 2005 82 89
39. M. Caragnano, P. Tortorella, A. Bergami, M. Ruggieri, P. Livrea, L.M. Specchio, and et al. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis Journal of Neuroimmunology 245 2012 93 97
40. W.A. Carroll, D.M. Kalvin, M.A. Perez, A.S. Florjancic, Y. Wang, D.L. Donnelly-Roberts, and et al. Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists Bioorganic & Medicinal Chemistry Letters 17 2007 4044 4048
41. T. Chataigneau, D. Lemoine, and T. Grutter Exploring the ATP-binding site of P2X receptors Frontiers in Cellular Neuroscience 7 2013 273
42. M.M. Chaves, C. Marques-da-Silva, A.P. Monteiro, C. Canetti, and R. Coutinho-Silva Leukotriene B4 modulates P2X7 receptor-mediated Leishmania amazonensis elimination in murine macrophages Journal of Immunology 192 2014 4765 4773
43. S.P. Chaves, E.C. Torres-Santos, C. Marques, V.R. Figliuolo, P.M. Persechini, R. Coutinho-Silva, and et al. Modulation of P2X(7) purinergic receptor in macrophages by Leishmania amazonensis and its role in parasite elimination Microbes and Infection 11 2009 842 849
44. B. Cheewatrakoolpong, H. Gilchrest, J.C. Anthes, and S. Greenfeder Identification and characterization of splice variants of the human P2X7 ATP channel Biochemical and Biophysical Research Communications 332 2005 17 27
45. Y.G. Chen, F. Scheuplein, J.P. Driver, A.A. Hewes, P.C. Reifsnyder, E.H. Leiter, and et al. Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice Journal of Immunology 186 2011 4278 4284
46. J.H. Chong, G.G. Zheng, X.F. Zhu, Y. Guo, L. Wang, C.H. Ma, and et al. Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias Biochemical and Biophysical Research Communications 391 2010 498 504
47. E.H. Choy, and G.S. Panayi Cytokine pathways and joint inflammation in rheumatoid arthritis The New England Journal of Medicine 344 2001 907 916
48. C. Coddou, S.S. Stojilkovic, and J.P. Huidobro-Toro Allosteric modulation of ATP-gated P2X receptor channels Reviews in the Neurosciences 22 2011 335 354
49. C. Coddou, Z. Yan, T. Obsil, J.P. Huidobro-Toro, and S.S. Stojilkovic Activation and regulation of purinergic P2X receptor channels Pharmacological Reviews 63 2011 641 683
50. R. Coutinho-Silva, T. Robson, P.E. Beales, and G. Burnstock Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes Autoimmunity 40 2007 108 116
51. R. Coutinho-Silva, L. Stahl, M.N. Raymond, T. Jungas, P. Verbeke, G. Burnstock, and et al. Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation Immunity 19 2003 403 412
52. D. Dal Ben, M. Buccioni, C. Lambertucci, G. Marucci, A. Thomas, and R. Volpini Purinergic P2X receptors: Structural models and analysis of ligand-target interaction European Journal of Medicinal Chemistry 89 2015 561 580
53. N. Dale, and B.G. Frenguelli Release of adenosine and ATP during ischemia and epilepsy Current Neuropharmacology 7 2009 160 179
54. L.P. Dao-Ung, S.J. Fuller, R. Sluyter, K.K. SkarRatt, U. Thunberg, G. Tobin, and et al. Association of the 1513C polymorphism in the P2X7 gene with familial forms of chronic lymphocytic leukaemia British Journal of Haematology 125 2004 815 817
55. T. Darville, L. Welter-Stahl, C. Cruz, A.A. Sater, C.W. Andrews Jr., and D.M. Ojcius Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice Journal of Immunology 179 2007 3707 3714
56. A. Davidson, and B. Diamond Autoimmune diseases The New England Journal of Medicine 345 2001 340 350
57. M. De Roo, J.L. Rodeau, and R. Schlichter Dehydroepiandrosterone potentiates native ionotropic ATP receptors containing the P2X2 subunit in rat sensory neurones The Journal of Physiology 552 2003 59 71
58. C. Delarasse, R. Auger, P. Gonnord, B. Fontaine, and J.M. Kanellopoulos The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein The Journal of Biological Chemistry 286 2011 2596 2606
59. L.C. Denlinger, D.B. Coursin, K. Schell, G. Angelini, D.N. Green, A.G. Guadarrama, and et al. Human P2X7 pore function predicts allele linkage disequilibrium Clinical Chemistry 52 2006 995 1004
60. F. Di Virgilio The therapeutic potential of modifying inflammasomes and NOD-like receptors Pharmacological Reviews 65 2013 872 905
61. F. Di Virgilio P2X receptors and inflammation Current Medicinal Chemistry 22 2015 866 877
62. M. Diaz-Hernandez, M. Diez-Zaera, J. Sanchez-Nogueiro, R. Gomez-Villafuertes, J.M. Canals, J. Alberch, and et al. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration The FASEB Journal 23 2009 1893 1906
63. D.L. Donnelly-Roberts, M.T. Namovic, P. Han, and M.F. Jarvis Mammalian P2X7 receptor pharmacology: Comparison of recombinant mouse, rat and human P2X7 receptors British Journal of Pharmacology 157 2009 1203 1214
64. D.L. Donnelly-Roberts, M.T. Namovic, B. Surber, S.X. Vaidyanathan, A. Perez-Medrano, Y. Wang, and et al. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors Neuropharmacology 56 2009 223 229
65. R.J. Evans Orthosteric and allosteric binding sites of P2X receptors European Biophysics Journal 38 2009 319 327
66. R.J. Evans Structural interpretation of P2X receptor mutagenesis studies on drug action British Journal of Pharmacology 161 2010 961 971
67. R.J. Evans, C. Lewis, G. Buell, S. Valera, R.A. North, and A. Surprenant Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors) Molecular Pharmacology 48 1995 178 183
68. I.P. Fairbairn, C.B. Stober, D.S. Kumararatne, and D.A. Lammas ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion Journal of Immunology 167 2001 3300 3307
69. S. Falk, S.D. Schwab, M. Frosig-Jorgensen, R.P. Clausen, A.H. Dickenson, and A.M. Heegaard P2X7 receptor-mediated analgesia in cancer-induced bone pain Neuroscience 291 2015 93 105
70. S. Falzoni, M. Munerati, D. Ferrari, S. Spisani, S. Moretti, and F. Di Virgilio The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role The Journal of Clinical Investigation 95 1995 1207 1216
71. J. Fang, X. Chen, L. Zhang, J. Chen, Y. Liang, X. Li, and et al. P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway The International Journal of Biochemistry & Cell Biology 45 2013 1109 1120
72. Y.H. Feng, X. Li, L. Wang, L. Zhou, and G.I. Gorodeski A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization The Journal of Biological Chemistry 281 2006 17228 17237
73. W.P. Feng, B. Zhang, W. Li, and J. Liu Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: A meta-analysis PloS One 9 2014 e88575
74. S.L. Fernando, B.M. Saunders, R. Sluyter, K.K. SkarRatt, H. Goldberg, G.B. Marks, and et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis American Journal of Respiratory and Critical Care Medicine 175 2007 360 366
75. A.S. Florjancic, S. Peddi, A. Perez-Medrano, B. Li, M.T. Namovic, G. Grayson, and et al. Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists Bioorganic & Medicinal Chemistry Letters 18 2008 2089 2092
76. C. Fotino, A. Vergani, P. Fiorina, and A. Pileggi P2X receptors and diabetes Current Medicinal Chemistry 22 2015 891 901
77. A. Franceschini, and E. Adinolfi P2X receptors: New players in cancer pain World Journal of Biological Chemistry 5 2014 429 436
78. A. Franceschini, M. Capece, P. Chiozzi, S. Falzoni, J.M. Sanz, A.C. Sarti, and et al. The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein The FASEB Journal 29 2015 2450 2461
79. S.A. Friedle, M.A. Curet, and J.J. Watters Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation Recent Patents on CNS Drug Discovery 5 2010 35 45
80. J. Fucikova, I. Moserova, L. Urbanova, L. Bezu, O. Kepp, I. Cremer, and et al. Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer Frontiers in Immunology 6 2015 402
81. A. Gartland, K.A. Buckley, R.A. Hipskind, W.B. Bowler, and J.A. Gallagher P2 receptors in bone - Modulation of osteoclast formation and activity via P2X7 activation Critical Reviews in Eukaryotic Gene Expression 13 2003 237 242
82. A. Gartland, K.A. Buckley, R.A. Hipskind, M.J. Perry, J.H. Tobias, G. Buell, and et al. Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice Critical Reviews in Eukaryotic Gene Expression 13 2003 243 253
83. A. Gartland, R.A. Hipskind, J.A. Gallagher, and W.B. Bowler Expression of a P2X7 receptor by a subpopulation of human osteoblasts Journal of Bone and Mineral Research 16 2001 846 856
84. A. Gartland, K.K. Skarratt, L.J. Hocking, C. Parsons, L. Stokes, N.R. Jorgensen, and et al. Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women European Journal of Human Genetics 20 2012 559 564
85. M.P. Gehring, F. Kipper, N.F. Nicoletti, N.D. Sperotto, R. Zanin, A.S. Tamajusuku, and et al. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival The International Journal of Biochemistry & Cell Biology 68 2015 92 100
86. M.P. Gehring, T.C. Pereira, R.F. Zanin, M.C. Borges, F.A. Braga, A.M. Battastini, and et al. P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line Purinergic Signal 8 2012 729 739
87. A. Ghalali, F. Wiklund, H. Zheng, U. Stenius, and J. Hogberg Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells Carcinogenesis 35 2014 1547 1555
88. A.L. Giuliani, D. Colognesi, T. Ricco, C. Roncato, M. Capece, F. Amoroso, and et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma PloS One 9 2014 e107224
89. R. Glas, N.S. Sauter, F.T. Schulthess, L. Shu, J. Oberholzer, and K. Maedler Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival Diabetologia 52 2009 1579 1588
90. E.K. Green, D. Grozeva, R. Raybould, G. Elvidge, S. Macgregor, I. Craig, and et al. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 150B 2009 1063 1069
91. L. Grimes, and M.T. Young Purinergic P2X receptors: Structural and functional features depicted by X-ray and molecular modelling studies Current Medicinal Chemistry 22 2015 783 798
92. M.W. Grol, I. Zelner, and S.J. Dixon P2X(7)-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells American Journal of Physiology. Endocrinology and Metabolism 302 2012 E561 E575
93. B.J. Gu, J. Field, S. Dutertre, A. Ou, T.J. Kilpatrick, J. Lechner-Scott, and et al. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis Human Molecular Genetics 24 2015 5644 5654
94. L.Q. Gu, F.Y. Li, L. Zhao, Y. Liu, Q. Chu, X.X. Zang, and et al. Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma Endocrine 38 2010 276 282
95. B.J. Gu, R. Sluyter, K.K. Skarratt, A.N. Shemon, L.P. Dao-Ung, S.J. Fuller, and et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor The Journal of Biological Chemistry 279 2004 31287 31295
96. B.J. Gu, W. Zhang, R.A. Worthington, R. Sluyter, P. Dao-Ung, S. Petrou, and et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor The Journal of Biological Chemistry 276 2001 11135 11142
97. S.D. Guile, L. Alcaraz, T.N. Birkinshaw, K.C. Bowers, M.R. Ebden, M. Furber, and et al. Antagonists of the P2X(7) receptor. From lead identification to drug development Journal of Medicinal Chemistry 52 2009 3123 3141
98. H. Gunosewoyo, and M. Kassiou P2X purinergic receptor ligands: Recently patented compounds Expert Opinion on Therapeutic Patents 20 2010 625 646
99. H. Guo, J.B. Callaway, and J.P. Ting Inflammasomes: Mechanism of action, role in disease, and therapeutics Nature Medicine 21 2015 677 687
100. R.R. Hansen, A. Nasser, S. Falk, S.B. Baldvinsson, P.H. Ohlsson, J.M. Bahl, and et al. Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice European Journal of Pharmacology 688 2012 27 34
101. M. Hattori, and E. Gouaux Molecular mechanism of ATP binding and ion channel activation in P2X receptors Nature 485 2012 207 212
102. F. Hattori, Y. Ohshima, S. Seki, M. Tsukimoto, M. Sato, T. Takenouchi, and et al. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7 European Journal of Pharmacology 695 2012 20 26
103. R. Hausmann, A. Kless, and G. Schmalzing Key sites for P2X receptor function and multimerization: Overview of mutagenesis studies on a structural basis Current Medicinal Chemistry 22 2015 799 818
104. A.D. Hibell, E.J. Kidd, I.P. Chessell, P.P. Humphrey, and A.D. Michel Apparent species differences in the kinetic properties of P2X(7) receptors British Journal of Pharmacology 130 2000 167 173
105. A.D. Hibell, K.M. Thompson, J. Simon, M. Xing, P.P. Humphrey, and A.D. Michel Species- and agonist-dependent differences in the deactivation-kinetics of P2X7 receptors Naunyn-Schmiedeberg's Archives of Pharmacology 363 2001 639 648
106. P. Hofman, J. Cherfils-Vicini, M. Bazin, M. Ilie, T. Juhel, X. Hebuterne, and et al. Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer Cancer Research 75 2015 835 845
107. P. Honore, D. Donnelly-Roberts, M.T. Namovic, G. Hsieh, C.Z. Zhu, J.P. Mikusa, and et al. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat The Journal of Pharmacology and Experimental Therapeutics 319 2006 1376 1385
108. P. Honore, D. Donnelly-Roberts, M. Namovic, C. Zhong, C. Wade, P. Chandran, and et al. The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1alphabeta knockout mice Behavioural Brain Research 204 2009 77 81
109. L.B. Husted, T. Harslof, L. Stenkjaer, M. Carstens, N.R. Jorgensen, and B.L. Langdahl Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis Osteoporosis International 24 2013 949 959
110. B. Jelassi, M. Anchelin, J. Chamouton, M.L. Cayuela, L. Clarysse, J. Li, and et al. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors Carcinogenesis 34 2013 1487 1496
111. B. Jelassi, A. Chantome, F. Alcaraz-Perez, A. Baroja-Mazo, M.L. Cayuela, P. Pelegrin, and et al. P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness Oncogene 30 2011 2108 2122
112. A. Jimenez-Pacheco, G. Mesuret, A. Sanz-Rodriguez, K. Tanaka, C. Mooney, R. Conroy, and et al. Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079 Epilepsia 54 2013 1551 1561
113. X.H. Jin, L.N. Wang, J.L. Zuo, J.P. Yang, and S.L. Liu P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain Journal of Neuroscience Research 92 2014 1690 1702
114. N.R. Jorgensen, Z. Henriksen, O.H. Sorensen, E.F. Eriksen, R. Civitelli, and T.H. Steinberg Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors The Journal of Biological Chemistry 277 2002 7574 7580
115. N.R. Jorgensen, L.B. Husted, K.K. Skarratt, L. Stokes, C.L. Tofteng, T. Kvist, and et al. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures European Journal of Human Genetics 20 2012 675 681
116. T.K. Kaan, P.K. Yip, S. Patel, M. Davies, F. Marchand, D.A. Cockayne, and et al. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats Brain 133 2010 2549 2564
117. K. Kaczmarek-Hajek, E. Lorinczi, R. Hausmann, and A. Nicke Molecular and functional properties of P2X receptors - Recent progress and persisting challenges Purinergic Signal 8 2012 375 417
118. K. Kaila, E. Ruusuvuori, P. Seja, J. Voipio, and M. Puskarjov GABA actions and ionic plasticity in epilepsy Current Opinion in Neurobiology 26 2014 34 41
119. J.A. Kanis An update on the diagnosis of osteoporosis Current Rheumatology Reports 2 2000 62 66
120. T. Kawate, J.C. Michel, W.T. Birdsong, and E. Gouaux Crystal structure of the ATP-gated P2X(4) ion channel in the closed state Nature 460 2009 592 598
121. H.Z. Ke, H. Qi, A.F. Weidema, Q. Zhang, N. Panupinthu, D.T. Crawford, and et al. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption Molecular Endocrinology 17 2003 1356 1367
122. J.Y. Kim, A.R. Ko, and J.E. Kim P2X7 receptor-mediated PARP1 activity regulates astroglial death in the rat hippocampus following status epilepticus Frontiers in Cellular Neuroscience 9 2015 352
123. J.R. Klein, and N.S. Olsen Effect of convulsive activity upon the concentration of brain glucose, glycogen, lactate, and phosphates The Journal of Biological Chemistry 167 1947 747 756
124. R.M. Koffie, T. Hashimoto, H.C. Tai, K.R. Kay, A. Serrano-Pozo, D. Joyner, and et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-beta Brain 135 2012 2155 2168
125. Q. Kong, K. Takahashi, D. Schulte, N. Stouffer, Y. Lin, and C.L. Lin Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus Neurobiology of Disease 47 2012 145 154
126. C. Lambertucci, D. Dal Ben, M. Buccioni, G. Marucci, A. Thomas, and R. Volpini Medicinal chemistry of P2X receptors: Agonists and orthosteric antagonists Current Medicinal Chemistry 22 2015 915 928
127. H.G. Lee, S.M. Won, B.J. Gwag, and Y.B. Lee Microglial P2X(7) receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease Experimental & Molecular Medicine 43 2011 7 14
128. L.Y. Lenertz, M.L. Gavala, Y. Zhu, and P.J. Bertics Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions Immunologic Research 50 2011 22 38
129. Y.Y. Leung, L.L. Yao Hui, and V.B. Kraus Colchicine - Update on mechanisms of action and therapeutic uses Seminars in Arthritis and Rheumatism 45 2015 341 350
130. C.M. Li, S.J. Campbell, D.S. Kumararatne, R. Bellamy, C. Ruwende, K.P. McAdam, and et al. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population The Journal of Infectious Diseases 186 2002 1458 1462
131. J. Li, D. Liu, H.Z. Ke, R.L. Duncan, and C.H. Turner The P2X7 nucleotide receptor mediates skeletal mechanotransduction The Journal of Biological Chemistry 280 2005 42952 42959
132. J. Li, R. Meyer, R.L. Duncan, and C.H. Turner P2X7 nucleotide receptor plays an important role in callus remodeling during fracture repair Calcified Tissue International 84 2009 405 412
133. J. Lindsay, E. Sykes, I. McDowell, R. Verreault, and D. Laurin More than the epidemiology of Alzheimer's disease: Contributions of the Canadian Study of Health and Aging Canadian Journal of Psychiatry 49 2004 83 91
134. D. Liu, D.C. Genetos, Y. Shao, D.J. Geist, J. Li, H.Z. Ke, and et al. Activation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2 +)- and ATP-dependent in MC3T3-E1 osteoblasts Bone 42 2008 644 652
135. E. Lorinczi, Y. Bhargava, S.F. Marino, A. Taly, K. Kaczmarek-Hajek, A. Barrantes-Freer, and et al. Involvement of the cysteine-rich head domain in activation and desensitization of the P2X1 receptor Proceedings of the National Academy of Sciences of the United States of America 109 2012 11396 11401
136. S. Lucae, D. Salyakina, N. Barden, M. Harvey, B. Gagne, M. Labbe, and et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder Human Molecular Genetics 15 2006 2438 2445
137. A.B. MacKenzie, A. Surprenant, and R.A. North Functional and molecular diversity of purinergic ion channel receptors Annals of the New York Academy of Sciences 868 1999 716 729
138. C. Marques-da-Silva, M.M. Chaves, N.G. Castro, R. Coutinho-Silva, and M.Z. Guimaraes Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: Implications for its therapeutic action British Journal of Pharmacology 163 2011 912 926
139. M. Masin, C. Young, K. Lim, S.J. Barnes, X.J. Xu, V. Marschall, and et al. Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: Re-evaluation of P2X7 knockouts British Journal of Pharmacology 165 2012 978 993
140. C. Matute, I. Torre, F. Perez-Cerda, A. Perez-Samartin, E. Alberdi, E. Etxebarria, and et al. P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis The Journal of Neuroscience 27 2007 9525 9533
141. A. McQuillin, N.J. Bass, K. Choudhury, V. Puri, M. Kosmin, J. Lawrence, and et al. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders Molecular Psychiatry 14 2009 614 620
142. R. Medzhitov Inflammation 2010: New adventures of an old flame Cell 140 2010 771 776
143. N. Mehta, M. Kaur, M. Singh, S. Chand, B. Vyas, P. Silakari, and et al. Purinergic receptor P2X(7): A novel target for anti-inflammatory therapy Bioorganic & Medicinal Chemistry 22 2014 54 88
144. C.M. Miller, N.R. Boulter, S.J. Fuller, A.M. Zakrzewski, M.P. Lees, B.M. Saunders, and et al. The role of the P2X(7) receptor in infectious diseases PLoS Pathogens 7 2011 e1002212
145. M.T. Miras-Portugal, J.I. Diaz-Hernandez, R. Gomez-Villafuertes, M. Diaz-Hernandez, A.R. Artalejo, and J. Gualix Role of P2X7 and P2Y2 receptors on alpha-secretase-dependent APP processing: Control of amyloid plaques formation "in vivo" by P2X7 receptor Computational and Structural Biotechnology Journal 13 2015 176 181
146. O. Mistafa, and U. Stenius Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells Biochemical Pharmacology 78 2009 1115 1126
147. I. Mokrousov, N. Sapozhnikova, and O. Narvskaya Mycobacterium tuberculosis co-existence with humans: Making an imprint on the macrophage P2X(7) receptor gene? Journal of Medical Microbiology 57 2008 581 584
148. M.J. Morytko, P. Betschmann, K. Woller, A. Ericsson, H. Chen, D.L. Donnelly-Roberts, and et al. Synthesis and in vitro activity of N′-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists Bioorganic & Medicinal Chemistry Letters 18 2008 2093 2096
149. C.E. Muller Medicinal chemistry of P2X receptors: Allosteric modulators Current Medicinal Chemistry 22 2015 929 941
150. R.H. Myers, M.E. MacDonald, W.J. Koroshetz, M.P. Duyao, C.M. Ambrose, S.A. Taylor, and et al. De novo expansion of a (CAG)n repeat in sporadic Huntington's disease Nature Genetics 5 1993 168 173
151. D.W. Nelson, R.J. Gregg, M.E. Kort, A. Perez-Medrano, E.A. Voight, Y. Wang, and et al. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists Journal of Medicinal Chemistry 49 2006 3659 3666
152. A. Nicke, Y.H. Kuan, M. Masin, J. Rettinger, B. Marquez-Klaka, O. Bender, and et al. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice The Journal of Biological Chemistry 284 2009 25813 25822
153. P. Nino-Moreno, D. Portales-Perez, B. Hernandez-Castro, L. Portales-Cervantes, V. Flores-Meraz, L. Baranda, and et al. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis Clinical and Experimental Immunology 148 2007 469 477
154. R.A. North, and M.F. Jarvis P2X receptors as drug targets Molecular Pharmacology 83 2013 759 769
155. S.D. Ohlendorff, C.L. Tofteng, J.E. Jensen, S. Petersen, R. Civitelli, M. Fenger, and et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment Pharmacogenetics and Genomics 17 2007 555 567
156. Y. Ohshima, M. Tsukimoto, T. Takenouchi, H. Harada, A. Suzuki, M. Sato, and et al. gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells Biochimica et Biophysica Acta 1800 2010 40 46
157. S. Paneesha, J. Starczynski, C. Pepper, J. Delgado, L. Hooper, C. Fegan, and et al. The P2X7 receptor gene polymorphism 1513 A - >C has no effect on clinical prognostic markers and survival in multiple myeloma Leukemia & Lymphoma 47 2006 281 284
158. N. Panupinthu, J.T. Rogers, L. Zhao, L.P. Solano-Flores, F. Possmayer, S.M. Sims, and et al. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis The Journal of Cell Biology 181 2008 859 871
159. P. Pellegatti, S. Falzoni, G. Donvito, I. Lemaire, and F. Di Virgilio P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration The FASEB Journal 25 2011 1264 1274
160. A. Perez-Medrano, D.L. Donnelly-Roberts, P. Honore, G.C. Hsieh, M.T. Namovic, S. Peddi, and et al. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain Journal of Medicinal Chemistry 52 2009 3366 3376
161. T. Philips, and W. Robberecht Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease Lancet Neurology 10 2011 253 263
162. R. Placido, G. Auricchio, S. Falzoni, L. Battistini, V. Colizzi, E. Brunetti, and et al. P2X(7) purinergic receptors and extracellular ATP mediate apoptosis of human monocytes/macrophages infected with Mycobacterium tuberculosis reducing the intracellular bacterial viability Cellular Immunology 244 2006 10 18
163. J. Pol, E. Vacchelli, F. Aranda, F. Castoldi, A. Eggermont, I. Cremer, and et al. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy Oncoimmunology 4 2015 e1008866
164. A.M. Pooler, W. Noble, and D.P. Hanger A role for tau at the synapse in Alzheimer's disease pathogenesis Neuropharmacology 76 Pt. A 2014 1 8
165. L. Portales-Cervantes, P. Nino-Moreno, M. Salgado-Bustamante, M.H. Garcia-Hernandez, L. Baranda-Candido, E. Reynaga-Hernandez, and et al. The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis Cellular Immunology 276 2012 168 175
166. Y. Qiu, W.H. Li, H.Q. Zhang, Y. Liu, X.X. Tian, and W.G. Fang P2X7 mediates ATP-driven invasiveness in prostate cancer cells PloS One 9 2014 e114371
167. R.M. Ransohoff, D.A. Hafler, and C.F. Lucchinetti Multiple sclerosis - A quiet revolution Nature Reviews. Neurology 11 2015 134 142
168. S. Ren, Y. Zhang, Y. Wang, Y. Lui, W. Wei, X. Huang, and et al. Targeting P2X(7) receptor inhibits the metastasis of murine P388D1 lymphoid neoplasm cells to lymph nodes Cell Biology International 34 2010 1205 1211
169. T. Riedel, S. Wiese, A. Leichsenring, and P. Illes Effects of nucleotide analogs at the P2X3 receptor and its mutants identify the agonist binding pouch Molecular Pharmacology 82 2012 80 89
170. J.K. Ryu, N. Jantaratnotai, M.C. Serrano-Perez, P.L. McGeer, and J.G. McLarnon Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model Journal of Neuropathology and Experimental Neurology 70 2011 13 22
171. V. Sambasivan, K.J. Murthy, R. Reddy, V. Vijayalakshimi, and Q. Hasan P2X7 gene polymorphisms and risk assessment for pulmonary tuberculosis in Asian Indians Disease Markers 28 2010 43 48
172. J.M. Sanz, P. Chiozzi, D. Ferrari, M. Colaianna, M. Idzko, S. Falzoni, and et al. Activation of microglia by amyloid {beta} requires P2X7 receptor expression Journal of Immunology 182 2009 4378 4385
173. J.M. Sanz, S. Falzoni, R. Rizzo, F. Cipollone, G. Zuliani, and F. Di Virgilio Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease Experimental Gerontology 60 2014 117 119
174. K. Sea, S.H. Sohn, A. Durazo, Y. Sheng, B.F. Shaw, X. Cao, and et al. Insights into the role of the unusual disulfide bond in copper-zinc superoxide dismutase The Journal of Biological Chemistry 290 2015 2405 2418
175. M. Shabbir, C. Thompson, M. Jarmulowiczc, D. Mikhailidis, and G. Burnstock Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo BJU International 102 2008 108 112
176. S. Sharma, V. Kumar, R. Khosla, N. Kajal, B. Sarin, and P. Sehajpal Association of P2X7 receptor + 1513 (A - >C) polymorphism with tuberculosis in a Punjabi population The International Journal of Tuberculosis and Lung Disease 14 2010 1159 1163
177. A.N. Shemon, R. Sluyter, S.L. Fernando, A.L. Clarke, L.P. Dao-Ung, K.K. Skarratt, and et al. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages The Journal of Biological Chemistry 281 2006 2079 2086
178. E. Shink, M. Harvey, M. Tremblay, B. Gagne, P. Belleau, C. Raymond, and et al. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 135B 2005 50 58
179. S.D. Skaper, L. Facci, A.A. Culbert, N.A. Evans, I. Chessell, J.B. Davis, and et al. P2X(7) receptors on microglial cells mediate injury to cortical neurons in vitro Glia 54 2006 234 242
180. K.K. Skarratt, S.J. Fuller, R. Sluyter, L.P. Dao-Ung, B.J. Gu, and J.S. Wiley A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population FEBS Letters 579 2005 2675 2678
181. A. Solini, P. Chiozzi, A. Morelli, E. Adinolfi, R. Rizzo, O.R. Baricordi, and et al. Enhanced P2X7 activity in human fibroblasts from diabetic patients: A possible pathogenetic mechanism for vascular damage in diabetes Arteriosclerosis, Thrombosis, and Vascular Biology 24 2004 1240 1245
182. A. Solini, V. Simeon, L. Derosa, P. Orlandi, C. Rossi, A. Fontana, and et al. Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients Oncotarget 6 2015 28743 28754
183. J.M. Somers, E.M. Goldner, P. Waraich, and L. Hsu Prevalence and incidence studies of anxiety disorders: A systematic review of the literature Canadian Journal of Psychiatry 51 2006 100 113
184. N. Soni, P. Koushal, B.V. Reddy, R. Deshmukh, and P. Kumar Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats Epilepsy & Behavior 48 2015 4 14
185. B. Sperlagh, and P. Illes P2X7 receptor: An emerging target in central nervous system diseases Trends in Pharmacological Sciences 35 2014 537 547
186. B. Sperlagh, A. Kofalvi, J. Deuchars, L. Atkinson, C.J. Milligan, N.J. Buckley, and et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus Journal of Neurochemistry 81 2002 1196 1211
187. B. Sperlagh, E.S. Vizi, K. Wirkner, and P. Illes P2X7 receptors in the nervous system Progress in Neurobiology 78 2006 327 346
188. L. Steinman Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system Cell 85 1996 299 302
189. A. Surprenant, F. Rassendren, E. Kawashima, R.A. North, and G. Buell The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7) Science 272 1996 735 738
190. M. Tafani, L. Schito, L. Pellegrini, L. Villanova, G. Marfe, T. Anwar, and et al. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B Carcinogenesis 32 2011 1167 1175
191. E. Takai, M. Tsukimoto, H. Harada, and S. Kojima Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells Purinergic Signal 10 2014 487 497
192. E. Takai, M. Tsukimoto, H. Harada, K. Sawada, Y. Moriyama, and S. Kojima Autocrine regulation of TGF-beta1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells Journal of Cell Science 125 2012 5051 5060
193. U. Thunberg, G. Tobin, A. Johnson, O. Soderberg, L. Padyukov, M. Hultdin, and et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia Lancet 360 2002 1935 1939
194. J.N. Todd, W. Poon, V. Lyssenko, L. Groop, B. Nichols, M. Wilmot, and et al. Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans The Journal of Clinical Endocrinology and Metabolism 100 2015 E688 E696
195. H.K. Tsao, P.H. Chiu, and S.H. Sun PKC-dependent ERK phosphorylation is essential for P2X7 receptor-mediated neuronal differentiation of neural progenitor cells Cell Death & Disease 4 2013 e751
196. D. Ursu, P. Ebert, E. Langron, C. Ruble, L. Munsie, W. Zou, and et al. Gain and loss of function of P2X7 receptors: Mechanisms, pharmacology and relevance to diabetic neuropathic pain Molecular Pain 10 2014 37
197. A.J. Vangsted, T.W. Klausen, P. Gimsing, N. Abildgaard, N.F. Andersen, A.O. Gang, and et al. Genetic variants in the P2RX7 gene are associated with risk of multiple myeloma European Journal of Haematology 93 2014 172 174
198. F.G. Vazquez-Cuevas, A.S. Martinez-Ramirez, L. Robles-Martinez, E. Garay, A. Garcia-Carranca, D. Perez-Montiel, and et al. Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells Journal of Cellular Biochemistry 115 2014 1955 1966
199. A. Vergani, C. Fotino, F. D'Addio, S. Tezza, M. Podetta, F. Gatti, and et al. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection Diabetes 62 2013 1665 1675
200. I. Vergne, J. Chua, H.H. Lee, M. Lucas, J. Belisle, and V. Deretic Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis Proceedings of the National Academy of Sciences of the United States of America 102 2005 4033 4038
201. E.P. Vianna, A.T. Ferreira, M.G. Naffah-Mazzacoratti, E.R. Sanabria, M. Funke, E.A. Cavalheiro, and et al. Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: Fluorimetric, immunohistochemical, and Western blot studies Epilepsia 43 Suppl. 5 2002 227 229
202. M. Viikki, O. Kampman, S. Anttila, A. Illi, E. Setala-Soikkeli, M. Huuhka, and et al. P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT Neuroscience Letters 493 2011 127 130
203. C. Volonte, S. Apolloni, S.D. Skaper, and G. Burnstock P2X7 receptors: Channels, pores and more CNS & Neurological Disorders Drug Targets 11 2012 705 721
204. R. Volpini, R.C. Mishra, D.D. Kachare, D. Dal Ben, C. Lambertucci, I. Antonini, and et al. Adenine-based acyclic nucleotides as novel P2X3 receptor ligands Journal of Medicinal Chemistry 52 2009 4596 4603
205. X. Wang, G. Arcuino, T. Takano, J. Lin, W.G. Peng, P. Wan, and et al. P2X7 receptor inhibition improves recovery after spinal cord injury Nature Medicine 10 2004 821 827
206. X. Wang, H. Xiao, H. Lan, C. Mao, and Q. Chen Lack of association between the P2X7 receptor A1513C polymorphism and susceptibility to pulmonary tuberculosis: A meta-analysis Respirology 16 2011 790 795
207. M.J. Wasserman, T.W. Corson, D. Sibony, R.G. Cooke, S.V. Parikh, P.S. Pennefather, and et al. Chronic lithium treatment attenuates intracellular calcium mobilization Neuropsychopharmacology 29 2004 759 769
208. A. Wesselius, M.J. Bours, Z. Henriksen, S. Syberg, S. Petersen, P. Schwarz, and et al. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients Osteoporosis International 24 2013 1235 1246
209. N. White, G.E. Knight, P.E. Butler, and G. Burnstock An in vivo model of melanoma: Treatment with ATP Purinergic Signal 5 2009 327 333
210. J.S. Wiley, L.P. Dao-Ung, B.J. Gu, R. Sluyter, A.N. Shemon, C. Li, and et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: A molecular study Lancet 359 2002 1114 1119
211. J.S. Wiley, L.P. Dao-Ung, C. Li, A.N. Shemon, B.J. Gu, M.L. Smart, and et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor The Journal of Biological Chemistry 278 2003 17108 17113
212. C. Wolf, C. Rosefort, G. Fallah, M.U. Kassack, A. Hamacher, M. Bodnar, and et al. Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking Molecular Pharmacology 79 2011 649 661
213. H. Wu, Y. Nie, H. Xiong, S. Liu, G. Li, A. Huang, and et al. P2X receptor expression in peripheral blood monocytes is correlated with plasma C-reactive protein and cytokine levels in patients with type 2 diabetes mellitus: A preliminary report Inflammation 38 2015 2076 2081
214. G. Wu, M. Zhao, X. Gu, Y. Yao, H. Liu, and Y. Song The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis: A meta-analysis Infection, Genetics and Evolution 24 2014 82 91
215. J. Xia, X. Yu, L. Tang, G. Li, and T. He P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway Oncology Reports 34 2015 103 110
216. J. Xiao, L. Sun, H. Yan, W. Jiao, Q. Miao, W. Feng, and et al. Metaanalysis of P2X7 gene polymorphisms and tuberculosis susceptibility FEMS Immunology and Medical Microbiology 60 2010 165 170
217. Y. Yang, H. Li, T.T. Li, H. Luo, X.Y. Gu, N. Lu, and et al. Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18 The Journal of Neuroscience 35 2015 7950 7963
218. Y. Ye, K. Ono, D.G. Bernabe, C.T. Viet, V. Pickering, J.C. Dolan, and et al. Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers Acta Neuropathologica Communications 2 2014 62
219. Y. Yiangou, P. Facer, P. Durrenberger, I.P. Chessell, A. Naylor, C. Bountra, and et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord BMC Neurology 6 2006 12
220. A. Young, D. Mittal, J. Stagg, and M.J. Smyth Targeting cancer-derived adenosine: New therapeutic approaches Cancer Discovery 4 2014 879 888
221. L. Zhou, L. Luo, X. Qi, X. Li, and G.I. Gorodeski Regulation of P2X(7) gene transcription Purinergic Signal 5 2009 409 426